Article ID Journal Published Year Pages File Type
8790170 Urologic Oncology: Seminars and Original Investigations 2018 7 Pages PDF
Abstract
In our retrospective analysis low levels of AP at the start of treatment, systemic therapy applied after AA + P and treatment beyond PRP proved to be independent factors of longer OS in metastatic castration-resistant prostate cancer.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Oncology
Preview
Abiraterone acetate + prednisolone treatment beyond prostate specific antigen and radiographic progression in metastatic castration-resistant prostate cancer patients
Authors
, , , , , , , , , ,